Browse Entries
2396 results
Filters
| PDB ID | Title | Organism | UniProt | Res. (Å) | Oligo | QSbio Err |
|---|---|---|---|---|---|---|
| 6KE5 | Structure of CavAb in complex with Diltiazem and Amlodipine | Arcobacter butzleri RM4018 | A8Evm5 | 2.80 | 4mer | 2.700 |
| 6KKB | A novel agonist of THRb | Homo sapiens | P10828 | 1.60 | 1mer | 5.800 |
| 6KQI | Crystal Structure of protein1 | Homo sapiens | P21554 | 3.25 | 1mer | 1.800 |
| 6KU3 | Crystal structure of gibberellin 2-oxidase3 (GA2ox3)in rice | Oryza sativa subsp. japonica | Q8S0S6 | 2.15 | 4mer | 25.700 |
| 6KUN | Crystal structure of dioxygenase for auxin oxidation (DAO) in rice | Oryza sativa subsp. indica | Q01Ix6 | 2.00 | 2mer | 69.400 |
| 6KX3 | Crystal structure of RhoA protein with covalent inhibitor DC-Rhoin | Homo sapiens | P61586 | 1.98 | 1mer | 1.800 |
| 6LD2 | Zika NS5 polymerase domain | Zika virus (isolate ZIKV/Human/French Polynesia/10087PF/2013) | A0A024B7W1 | 1.40 | 1mer | 1.800 |
| 6LI0 | Crystal structure of GPR52 in complex with agonist c17 | Homo sapiens | Q9Y2T5 | 2.20 | 1mer | 1.800 |
| 6LMI | Crystal structure of HIV-1 integrase catalytic core domain in complex with 2-(tert-butoxy)-2-[3-(3,4-dihydro-2H-1-benzopyran-6-yl)-6-methanesulfonamido-2,3',4',5-tetramethyl-[1,1'-biphenyl]-4-yl]acetic acid | Human immunodeficiency virus type 1 group M subtype B (isolate NY5) | P12497 | 2.50 | 2mer | 6.500 |
| 6LMQ | Crystal structure of HIV-1 integrase catalytic core domain in complex with 2-(tert-butoxy)-2-[3-(3,4-dihydro-2H-1,4-benzoxazin-6-yl)-6-methanesulfonamido-2,3',4',5-tetramethyl-[1,1'-biphenyl]-4-yl]acetic acid | Human immunodeficiency virus type 1 group M subtype B (isolate NY5) | P12497 | 2.10 | 2mer | 6.500 |
| 6LS5 | Structure of human liver FBPase complexed with covalent allosteric inhibitor | Homo sapiens | Q2Tu34 | 2.03 | 4mer | 2.700 |
| 6MC1 | Structure of MAP kinase phosphatase 5 in complex with 3,3-dimethyl-1-((9-(methylthio)-5,6-dihydrothieno[3,4-h]quinazolin-2-yl)thio)butan-2-one, an allosteric inhibitor | Homo sapiens | Q9Y6W6 | 2.70 | 1mer | 1.800 |
| 6MD7 | Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor Pyrimidinone 7 | Homo sapiens | Q06124 | 1.96 | 1mer | 1.800 |
| 6MD9 | NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR Isoxazolo-pyridinone 3 | Homo sapiens | Q06124 | 2.12 | 1mer | 1.800 |
| 6MDA | Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor Pyrazolo-pyridine 4 | Homo sapiens | Q06124 | 2.21 | 1mer | 1.800 |
| 6MDB | Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor Pyrazolo-pyrimidinone 5 | Homo sapiens | Q06124 | 2.34 | 1mer | 1.800 |
| 6MDC | Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor Pyrazolo-pyrimidinone 1 SHP389 | Homo sapiens | Q06124 | 2.14 | 1mer | 1.800 |
| 6MDD | Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor Imidazo-pyridine 24 | Homo sapiens | Q06124 | 2.05 | 1mer | 1.800 |
| 6MGI | Photosynthetic phosphoenolpyruvate carboxylase isoenzyme from maize complexed with the allosteric activator glucose-6-phosphate in its allosteric site | Zea mays | Q84Kr7 | 2.99 | 4mer | 0.000 |
| 6MO0 | Structure of dengue virus protease with an allosteric Inhibitor that blocks replication | Dengue virus 2 | A0A0B4L2Y4 | 2.70 | 1mer | 5.800 |
| 6MO1 | Structure of dengue virus protease with an allosteric Inhibitor that blocks replication | Dengue virus 2 | B3Rft3 | 2.70 | 1mer | 5.800 |
| 6MO2 | Structure of dengue virus protease with an allosteric Inhibitor that blocks replication | Dengue virus 2 | A0A0B4L2Y4 | 2.60 | 1mer | 5.800 |
| 6MS7 | Peroxisome proliferator-activated receptor gamma ligand binding domain in complex with a novel selective PPAR-gamma modulator VSP-77 | Homo sapiens | P37231 | 1.41 | 1mer | 1.800 |
| 6N3N | Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents | Homo sapiens | Q9P2K8 | 3.00 | 1mer | 46.300 |
| 6N3O | Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents | Homo sapiens | Q9P2K8 | 2.40 | 1mer | 13.900 |